596 related articles for article (PubMed ID: 10580423)
21. Effects of the imidazoline binding site ligands, idazoxan and efaroxan, on the viability of insulin-secreting BRIN-BD11 cells.
Gao H; Mourtada M; Morgan NG
JOP; 2003 May; 4(3):117-24. PubMed ID: 12743417
[TBL] [Abstract][Full Text] [Related]
22. Selective enhancement of nutrient-induced insulin secretion by ATP-sensitive K+ channel-blocking imidazolines.
Hatlapatka K; Wienbergen A; Kühne C; Jörns A; Willenborg M; Rustenbeck I
J Pharmacol Exp Ther; 2009 Dec; 331(3):1033-41. PubMed ID: 19745109
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous characteristics of imidazoline-induced insulin secretion.
Rustenbeck I; Leupolt L; Kowalewski R; Hasselblatt A
Naunyn Schmiedebergs Arch Pharmacol; 1999 Mar; 359(3):235-42. PubMed ID: 10208311
[TBL] [Abstract][Full Text] [Related]
24. Antagonism of the insulinotropic action of first generation imidazolines by openers of K(ATP) channels.
Wienbergen A; Bleck C; Lackmann TG; Rustenbeck I
Biochem Pharmacol; 2007 Jan; 73(1):94-102. PubMed ID: 17056015
[TBL] [Abstract][Full Text] [Related]
25. Clotrimazole and efaroxan stimulate insulin secretion by different mechanisms in rat pancreatic islets.
Chan SL; Pallett AL; Morgan NG
Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):763-8. PubMed ID: 9453462
[TBL] [Abstract][Full Text] [Related]
26. Imidazoline antagonists of alpha 2-adrenoceptors increase insulin release in vitro by inhibiting ATP-sensitive K+ channels in pancreatic beta-cells.
Jonas JC; Plant TD; Henquin JC
Br J Pharmacol; 1992 Sep; 107(1):8-14. PubMed ID: 1358388
[TBL] [Abstract][Full Text] [Related]
27. Imidazolines stimulate release of insulin from RIN-5AH cells independently from imidazoline I1 and I2 receptors.
Olmos G; Kulkarni RN; Haque M; MacDermot J
Eur J Pharmacol; 1994 Sep; 262(1-2):41-8. PubMed ID: 7813577
[TBL] [Abstract][Full Text] [Related]
28. Imidazoline compounds stimulate insulin release by inhibition of K(ATP) channels and interaction with the exocytotic machinery.
Zaitsev SV; Efanov AM; Efanova IB; Larsson O; Ostenson CG; Gold G; Berggren PO; Efendić S
Diabetes; 1996 Nov; 45(11):1610-8. PubMed ID: 8866568
[TBL] [Abstract][Full Text] [Related]
29. Imidazoline NNC77-0074 stimulates insulin secretion and inhibits glucagon release by control of Ca(2+)-dependent exocytosis in pancreatic alpha- and beta-cells.
Høy M; Olsen HL; Andersen HS; Bokvist K; Buschard K; Hansen J; Jacobsen P; Petersen JS; Rorsman P; Gromada J
Eur J Pharmacol; 2003 Apr; 466(1-2):213-21. PubMed ID: 12679159
[TBL] [Abstract][Full Text] [Related]
30. Effects of putative activators of K+ channels in mouse pancreatic beta-cells.
Garrino MG; Plant TD; Henquin JC
Br J Pharmacol; 1989 Nov; 98(3):957-65. PubMed ID: 2531623
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of insulin secretion by efaroxan may involve interaction with potassium channels.
Chan SL; Morgan NG
Eur J Pharmacol; 1990 Jan; 176(1):97-101. PubMed ID: 2178947
[TBL] [Abstract][Full Text] [Related]
32. ATP-sensitive K+ channels may control glucose-induced electrical activity in pancreatic B-cells.
Henquin JC
Biochem Biophys Res Commun; 1988 Oct; 156(2):769-75. PubMed ID: 3056403
[TBL] [Abstract][Full Text] [Related]
33. Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. I. Secretory and morphological studies.
Rustenbeck I; Winkler M; Jörns A
Biochem Pharmacol; 2001 Dec; 62(12):1685-94. PubMed ID: 11755122
[TBL] [Abstract][Full Text] [Related]
34. In vitro mechanism of action on insulin release of S-22068, a new putative antidiabetic compound.
Le Brigand L; Virsolvy A; Manechez D; Godfroid JJ; Guardiola-Lemaître B; Gribble FM; Ashcroft FM; Bataille D
Br J Pharmacol; 1999 Nov; 128(5):1021-6. PubMed ID: 10556939
[TBL] [Abstract][Full Text] [Related]
35. Diazoxide-sensitivity of the adenosine 5'-triphosphate-dependent K+ channel in mouse pancreatic beta-cells.
Schwanstecher C; Dickel C; Ebers I; Lins S; Zünkler BJ; Panten U
Br J Pharmacol; 1992 Sep; 107(1):87-94. PubMed ID: 1422580
[TBL] [Abstract][Full Text] [Related]
36. Stimulation of insulin secretion in clonal BRIN-BD11 cells by the imidazoline derivatives KU14r and RX801080.
Ball AJ; Flatt PR; McClenaghan NH
Pharmacol Res; 2000 Dec; 42(6):575-9. PubMed ID: 11058411
[TBL] [Abstract][Full Text] [Related]
37. Activation of KATP channels by H2S in rat insulin-secreting cells and the underlying mechanisms.
Yang W; Yang G; Jia X; Wu L; Wang R
J Physiol; 2005 Dec; 569(Pt 2):519-31. PubMed ID: 16179362
[TBL] [Abstract][Full Text] [Related]
38. Effector systems involved in the insulin secretory responses to efaroxan and RX871024 in rat islets of Langerhans.
Mourtada M; Smith SA; Morgan NG
Eur J Pharmacol; 1998 Jun; 350(2-3):251-8. PubMed ID: 9696415
[TBL] [Abstract][Full Text] [Related]
39. Hyperinsulinism of infancy: the regulated release of insulin by KATP channel-independent pathways.
Straub SG; Cosgrove KE; Ammälä C; Shepherd RM; O'Brien RE; Barnes PD; Kuchinski N; Chapman JC; Schaeppi M; Glaser B; Lindley KJ; Sharp GW; Aynsley-Green A; Dunne MJ
Diabetes; 2001 Feb; 50(2):329-39. PubMed ID: 11272144
[TBL] [Abstract][Full Text] [Related]
40. Imidazoline/guanidinium binding sites and their relation to inhibition of K(ATP) channels in pancreatic B-cells.
Rustenbeck I; Herrmann C; Ratzka P; Hasselblatt A
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):410-7. PubMed ID: 9303581
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
